Thymic TFH cells involved in the pathogenesis of myasthenia gravis with thymoma

Experimental Neurology

Volumn 254, Issue , 2014, Pages 200-205

  Zhang, Min ^a   Zhou, Yongan ^a   Guo, Jun ^a   Li, Hongzeng ^a   Tian, Feng ^a   Gong, Li ^a   Wang, Xianni ^a   Lan, Miao ^a   Li, Zhuyi ^a   Zhang, Wei ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Generalized myasthenia gravis; Ocular myasthenia gravis; T follicular helper cells; Thymoma; Thymus

Indexed keywords

BIOLOGICAL MARKER; CHEMOKINE RECEPTOR CXCR5; INDUCIBLE T CELL COSTIMULATOR; INTERLEUKIN 21; MESSENGER RNA; PROTEIN BCL 6;

ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FOLLICULAR HELPER CD4+ T LYMPHOCYTE; GENE EXPRESSION; GENERALIZED MYASTHENIA GRAVIS; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MYASTHENIA GRAVIS; OCULAR MYASTHENIA GRAVIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; THYMOCYTE; THYMOMA; UPREGULATION; WESTERN BLOTTING;

GENERALIZED MYASTHENIA GRAVIS; OCULAR MYASTHENIA GRAVIS; T FOLLICULAR HELPER CELLS; THYMOMA; THYMUS;

CD4-POSITIVE T-LYMPHOCYTES; DNA-BINDING PROTEINS; HUMANS; INDUCIBLE T-CELL CO-STIMULATOR PROTEIN; INTERLEUKINS; MYASTHENIA GRAVIS; RECEPTORS, CXCR5; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; THYMECTOMY; THYMOMA; THYMUS GLAND; THYMUS NEOPLASMS;

EID: 84896707034     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2014.01.024     Document Type: Article

References (37)

1. Bossaller L., Burger J., Draeger R., Grimbacher B., Knoth R., Plebani A., Durandy A., Baumann U., Schlesier M., Welcher A.A., Peter H.H., Warnatz K. ICOS deficiency is associated with a severe reduction of CXCR5+CD4 germinal center Th cells. J. Immunol. 2006, 177:4927-4932.
2. Bryant V.L., Ma C.S., Avery D.T., Li Y., Good K.L., Corcoran L.M., de Waal Malefyt R., Tangye S.G. Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells. J. Immunol. 2007, 179:8180-8190.
3. Cannons J.L., Qi H., Lu K.T., Dutta M., Gomez-Rodriguez J., Cheng J., Wakeland E.K., Germain R.N., Schwartzberg P.L. Optimal germinal center responses require a multistage T cell:B cell adhesion process involving integrins, SLAM-associated protein, and CD84. Immunity 2010, 32:253-265.
4. Cavalcante P., Le Panse R., Berrih-Aknin S., Maggi L., Antozzi C., Baggi F., Bernasconi P., Mantegazza R. The thymus in myasthenia gravis: Site of "innate autoimmunity"?. Muscle Nerve 2011, 44:467-484.
5. Choi Y.S., Kageyama R., Eto D., Escobar T.C., Johnston R.J., Monticelli L., Lao C., Crotty S. ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6. Immunity 2011, 34:932-946.
6. Chtanova T., Tangye S.G., Newton R., Frank N., Hodge M.R., Rolph M.S., Mackay C.R. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J. Immunol. 2004, 173:68-78.
7. Fazilleau N., Mark L., McHeyzer-Williams L., McHeyzer-Williams M.G. Follicular helper T cells: lineage and location. Immunity 2009, 30:324-335.
8. Grob D., Brunner N., Namba T., Pagala M. Lifetime course of myasthenia gravis. Muscle Nerve 2008, 37:141-149.
9. Hellmann M.A., Mosberg-Galili R., Steiner I. Myasthenia gravis in the elderly. J. Neurol. Sci. 2013, 325:1-5.
10. Huang X., Reynolds A.D., Mosley R.L., Gendelman H.E. CD4+ T cells in the pathobiology of neurodegenerative disorders. J. Neuroimmunol. 2009, 211:3-15.
11. Iwai H., Kozono Y., Hirose S., Akiba H., Yagita H., Okumura K., Kohsaka H., Miyasaka N., Azuma M. Amelioration of collagen-induced arthritis by blockade of inducible costimulator-B7 homologous protein costimulation. J. Immunol. 2002, 169:4332-4339.
12. Jaretzki A., Barohn R.J., Ernstoff R.M., Kaminski H.J., Keesey J.C., Penn A.S., Sanders D.B. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Ann. Thorac. Surg. 2000, 70:327-334.
13. Kerfoot S.M., Yaari G., Patel J.R., Johnson K.L., Gonzalez D.G., Kleinstein S.H., Haberman A.M. Germinal center B cell and T follicular helper cell development initiates in the interfollicular zone. Immunity 2011, 34:947-960.
14. Kitano M., Moriyama S., Ando Y., Hikida M., Mori Y., Kurosaki T., Okada T. Bcl6 protein expression shapes pre-germinal center B cell dynamics and follicular helper T cell heterogeneity. Immunity 2011, 34:961-972.
15. Krol J., Loedige I., Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 2010, 11:597-610.
16. Laurent C., Fazilleau N., Brousset P. A novel subset of T-helper cells: follicular T-helper cells and their markers. Haematologica 2010, 95:356-358.
17. Li X., Xiao B.G., Xi J.Y., Lu C.Z., Lu J.H. Decrease of CD4(+) CD25 (high) Foxp3(+) regulatory T cells and elevation of CD19(+)BAFF-R(+) B cells and soluble ICAM-1 in myasthenia gravis. Clin. Immunol. 2008, 126:180-188.
18. Linterman M.A., Beaton L., Yu D., Ramiscal R.R., Srivastava M., Hogan J.J., Verma N.K., Smyth M.J., Rigby R.J., Vinuesa C.G. IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses. J. Exp. Med. 2010, 207:353-363.
19. Luo C., Li Y., Liu W., Feng H., Wang H., Huang X., Qiu L., Ouyang J. Expansion of circulating counterparts of follicular helper T cells in patients with myasthenia gravis. J. Neuroimmunol. 2013, 256:55-61.
20. Marx A., Wilisch A., Schultz A., Gattenlöhner S., Nenninger R., Müller-Hermelink H.K. Pathogenesis of myasthenia gravis. Virchows Arch. 1997, 430(5):355-364.
21. Matsumoto Y., Matsuo H., Sakuma H., Park I.K., Tsukada Y., Kohyama K., Kondo T., Kotorii S., Shibuya N. CDR3 spectratyping analysis of the TCR repertoire in myasthenia gravis. J. Immunol. 2006, 176:5100-5107.
22. Nurieva R.I., Treuting P., Duong J., Flavell R.A., Dong C. Inducible costimulator is essential for collagen-induced arthritis. J. Clin. Invest. 2003, 111:701-706.
23. Nurieva R.I., Chung Y., Martinez G.J., Yang X.O., Tanaka S., Matskevitch T.D., Wang Y.H., Dong C. Bcl6 mediates the development of T follicular helper. Science 2009, 325:1001-1005.
24. Remes-Troche J.M., Téllez-Zenteno J.F., Estañol B., Garduño-Espinoza J., García-Ramos G. Thymectomy in myasthenia gravis: response, complications, and associated conditions. Arch. Med. Res. 2002, 33:545-551.
25. Roxanis I., Micklem K., McConville J., Newsom-Davis J., Willcox N. Thymic myoid cells and germinal center formation in myasthenia gravis; possible roles in pathogenesis. J. Neuroimmunol. 2002, 125:185-197.
26. Saito R., Onodera H., Tago H., Suzuki Y., Shimizu M., Matsumura Y., Kondo T., Itoyama Y. Altered expression of chemokine receptor CXCR5 on T cells of myasthenia gravis patients. J. Neuroimmunol. 2005, 170:172-178.
27. Scott B.G., Yang H., Tüzün E., Dong C., Flavell R.A., Christadoss P. ICOS is essential for the development of experimental autoimmune myasthenia gravis. J. Neuroimmunol. 2004, 153:16-25.
28. Sheng J.R., Muthusamy T., Prabhakar B.S., Meriggioli M.N. GM-CSF-induced regulatory T cells selectively inhibit anti-acetylcholine receptor-specific immune responses in experimental myasthenia gravis. J. Neuroimmunol. 2011, 240-241:65-73.
29. Simpson N., Gatenby P.A., Wilson A., Malik S., Fulcher D.A., Tangye S.G., Manku H., Vyse T.J., Roncador G., Huttley G.A., Goodnow C.C., Vinuesa C.G., Cook M.C. Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus. Arthritis Rheum. 2010, 62:234-244.
30. Spolski R., Leonard W.J. IL-21 and T follicular helper cells. Int. Immunol. 2010, 22:7-12.
31. Ströbel P., Rosenwald A., Beyersdorf N., Kerkau T., Elert O., Murumägi A., Sillanpää N., Peterson P., Hummel V., Rieckmann P., Burek C., Schalke B., Nix W., Kiefer R., Müller-Hermelink H.K., Marx A. Selective loss of regulatory T cells in thymomas. Ann. Neurol. 2004, 56:901-904.
32. Vinuesa C.G., Sanz I., Cook M.C. Dysregulation of germinal centres in autoimmune disease. Nat. Rev. Immunol. 2009, 9:845-857.
33. Watanabe H. Thymoma and thymic germinal center. Keio J. Med. 1971, 20:69-75.
34. Yanaba K., Bouaziz J.D., Matsushita T., Magro C.M., St Clair E.W., Tedder T.F. B-lymphocyte contributions to human autoimmune disease. Immunol. Rev. 2008, 223:284-299.
35. Zhang X., Yang M., Xu J., Zhang M., Lang B., Wang W., Vincent A. Clinical and serological study of myasthenia gravis in HuBei Province, China. J. Neurol. Neurosurg. Psychiatry 2007, 78:386-390.
36. Zhang M., Li H., Guo J., Zhou Y., Gong L., Wang X., Li Z., Zhang W. Different molecular expression in thymoma with ocular or generalized myasthenia gravis. J. Neurol. Sci. 2012, 313:27-31.
37. Zhu C., Ma J., Liu Y., Tong J., Tian J., Chen J., Tang X., Xu H., Lu L., Wang S. Increased frequency of follicular helper T cells in patients with autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 2012, 97:943-950.